United Kingdom· GB-APID-33341411000001104
Mycophenolate mofetil 500mg powder for concentrate for solution for infusion vials
A medicinal product containing mycophenolate mofetil, registered in United Kingdom by Accord-UK Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Mycophenolate mofetil
- Manufacturer
- Accord-UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin5055565716229
- gtin05055565716229
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mycophenolate mofetil in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumCellcept 500 mgRoche Registration
- NorwayCellCeptRoche Registration GmbH
- SwedenCellCept 500 mg Pulver till koncentrat till infusionsvätska, lösningRoche Registration GmbH
- FinlandCellceptRoche Registration GmbH
- IrelandCellCept 500 mg Powder for concentrate for solution for infusionRoche Registration GmbH
- United StatesCellCeptGenentech, Inc.
- CzechiaCELLCEPTRoche Registration GmbH, Grenzach-Wyhlen
- CanadaACH-MYCOPHENOLATEACCORD HEALTHCARE INC
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Mowel, Mycophenolat Mofetil Sandoz
- Belgium · Mycophenolat Mofetil Sandoz
- Bulgaria · Микофенолат Мофетил Акорд
- Czechia · Mycophenolat Mofetil Sandoz
- Germany · Mowel, Mycophenolat 1 A Pharma
- Denmark · Mycophenolate Mofetil Hexal, Mycophenolatmofetil Accord
- Estonia · Mycophenolate Mofetil Accord
- Spain · Micofenolato De Mofetilo Accord, Micofenolato De Mofetilo Aristo
- Finland · Mycophenolate Mofetil Accord, Mycophenolate Mofetil Eql Pharma
- France · Mycophenolate Mofetil Arrow, Mycophenolate Mofetil Biogaran
- Croatia · Mofetilmikofenolat Tillomed, Trixin
- Ireland · Mycolat, Mycophenolate Mofetil Accord
- Iceland · Cellcept, Myclausen
- Italy · Micofenolato Mofetile Accord, Micofenolato Mofetile Ahcl
- Liechtenstein · Cellcept, Myclausen
- Lithuania · Mycophenolate Mofetil Accord
- Latvia · Mycophenolate Mofetil Accord
- Malta · Mycophenolate Mofetil Ascend
- Netherlands · Mycofenolaat Mofetil Accord, Mycofenolaat Mofetil Sandoz
- Norway · Cellcept, Myclausen
- Poland · Mycofit, Mycophenolate Mofetil Sandoz
- Portugal · Micofenolato De Mofetil Accord, Micofenolato De Mofetil Aristo
- Romania · Micofenolat Mofetil Sandoz
- Sweden · Mycophenolate Mofetil Accord, Mycophenolate Mofetil Eql Pharma
- Slovakia · Mykofenolát Mofetil Sandoz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c344f00f-ac3e-4afc-b45d-b25138f714bb GET /v1/drugs/c344f00f-ac3e-4afc-b45d-b25138f714bb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "33341411000001104",
"desc": "Mycophenolate mofetil 500mg powder for concentrate for solution for infusion vials (Accord-UK Ltd)",
"form": "Powder for solution for infusion",
"vpid": "41766111000001103",
"source": "dmd",
"vtm_id": "230381000001108",
"strength": "500 mg",
"substance": "Mycophenolate mofetil",
"ingredient": "Mycophenolate mofetil hydrochloride",
"supplier_code": "18471011000001103"
}See everything about mycophenolate mofetil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.